A Comparative Study of Longitudinal Toxicities of Cytotoxic Drugs, Molecularly Targeted Agents, Immunomodulatory Drugs, and Cancer Vaccines-Reference-Cited by-同舟云学术

A Comparative Study of Longitudinal Toxicities of Cytotoxic Drugs, Molecularly Targeted Agents, Immunomodulatory Drugs, and Cancer Vaccines

Published:2019-04-29 Issue:4 Volume:106 Page:803-809
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

Hirakawa Akihiro¹,Sudo Kazuki²,Yonemori Kan²³⁴,Sadachi Ryo¹,Kinoshita Fumie⁵,Kobayashi Yumiko⁵,Okuma Hitomi S.²,Kawachi Asuka²,Tamura Kenji²,Fujiwara Yasuhiro²,Rubinstein Larry⁶,Takebe Naoko⁴

Affiliation:

1. Department of Biostatistics and BioinformaticsGraduate School of MedicineThe University of Tokyo Tokyo Japan

2. Department of Breast and Medical OncologyNational Cancer Center HospitalNational Cancer Center Tokyo Japan

3. Department of Experimental TherapeuticsNational Cancer Center HospitalNational Cancer Center Tokyo Japan

4. Investigational Drug BranchCancer Therapy Evaluation ProgramDivision of Cancer Treatment and DiagnosisNational Cancer InstituteNational Institute of Health Rockville Maryland USA

5. Department of Advanced MedicineStatistical Analysis SectionNagoya University Hospital Aichi Japan

6. Biometric Research ProgramDivision of Cancer Treatment and DiagnosisNational Cancer InstituteNational Institute of Health Rockville Maryland USA

Funder

Japan Society for the Promotion of Science

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.1442

Reference28 articles.

1. Critical role of phase I clinical trials in cancer treatment. American Society of Clinical Oncology.

2. Clinical Trial Designs for Cytostatic Agents

3. Is the “3+3” Dose-Escalation Phase I Clinical Trial Design Suitable for Therapeutic Cancer Vaccine Development? A Recommendation for Alternative Design

4. Dose Finding of Small-Molecule Oncology Drugs: Optimization throughout the Development Life Cycle

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Racial differences in longitudinal toxicities of anticancer agents in early phase cancer clinical trials;Cancer Medicine;2023-07-31

2. Novel longitudinal Multiple Overall Toxicity (MOTox) score to quantify adverse events experienced by patients during chemotherapy treatment: a retrospective analysis of the MRC BO06 trial in osteosarcoma;BMJ Open;2021-12

3. Factors Influencing Classifications of Safety Specifications in a Risk Management Plan for Antineoplastic Agents Approved in Japan: A Review and Descriptive Analysis;Therapeutic Innovation & Regulatory Science;2021-06-09